McKesson (STU:MCK) Change In Payables And Accrued Expense : €4,273 Mil (TTM As of Mar. 2024)

View and export this data going back to 1987. Start your Free Trial

What is McKesson Change In Payables And Accrued Expense?

McKesson's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was €390 Mil. It means McKesson's Accounts Payable & Accrued Expense increased by €390 Mil from Dec. 2023 to Mar. 2024 .

McKesson's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was €4,220 Mil. It means McKesson's Accounts Payable & Accrued Expense increased by €4,220 Mil from Mar. 2023 to Mar. 2024 .

McKesson Change In Payables And Accrued Expense Historical Data

The historical data trend for McKesson's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Change In Payables And Accrued Expense Chart

McKesson Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

3,576.56

1,064.28

2,544.22

3,537.99

4,220.04

McKesson Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															240.04	1,359.58	2,655.46	-132.05	390.08

McKesson Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,273 Mil.

McKesson Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of McKesson's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson (STU:MCK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (STU:MCK) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MCK:USA M1CK34:Brazil

Address

6555 State Highway 161, Irving, TX, USA, 75039

Website

https://www.mckesson.com

McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.